Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...

During a live event, Konstantinos Sdrimas, MD, and community oncologists discussed patient concerns over CAR T-cell therapy ...

Stallergenes Greer, a global leader in allergy therapeutics, will present insightful scientific developments at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, Glasgow ...

"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...

Diagnosed with incurable cancer, Jonathan Gluck reveals how two decades of uncertainty taught him to find resilience through ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.

Samsung Bioepis Co., Ltd. ("Samsung Bioepis") today presented the long-term safety data of EPYSQLItm (eculizumab; SB12), a biosimilar to Soliris1, in paroxysmal nocturnal hemoglobinuria (PNH) at the ...

A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...

I reflect on finding peace, purpose and presence after my diagnosis through a creative writing exercise rooted in mindfulness ...

The dramatic bend in the curve of cancer deaths didn’t happen by accident — it’s the compound interest of three revolutions.

As cannabis use among youth rises in Canada—and THC potency reaches record highs—emergency departments are seeing a surge in ...